In Vitro Study to Evaluate the Best Conditions Highlighting the Antimicrobial Activity of Carum carvi Essential Oil on Human Pathogen Isolates in Formulations Against the Spread of Antibiotic Resistance
Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential...
Saved in:
Published in | Pharmaceuticals (Basel, Switzerland) Vol. 18; no. 3; p. 321 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
25.02.2025
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography–mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM−. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections. |
---|---|
AbstractList | Background/Objectives
: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like
Carum carvi
essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration.
Methods
: CC-EO quality was evaluated using gas chromatography–mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to
S. aureus
,
E. coli
,
E. faecalis
,
K. pneumoniae
,
P. aeruginosa
,
S. pyogenes
, and
C. albicans
was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test.
Results
: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and
C. albicans
strains, both sensible and resistant, and ineffective against GRAM−.
Conclusions
: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and
C. albicans
infections. Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography-mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM-. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections.Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography-mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM-. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections. Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography–mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM−. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections. : In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. : CC-EO quality was evaluated using gas chromatography-mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to , , , , , , and was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. : The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and strains, both sensible and resistant, and ineffective against GRAM-. : In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and infections. |
Audience | Academic |
Author | Vito, Maura Di Mercurio, Mattia Di La Sorda, Marilena Rizzo, Silvia Mariotti, Melinda Zhiri, Abdesselam Mastrella, Carolina Garzoli, Stefania Sanguinetti, Maurizio Bugli, Francesca |
AuthorAffiliation | 4 R&D Department, Pranarom International, 37 Avenue des Artisans, 7822 Ghislenghien, Belgium; azhiri@pranarom.com 3 Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy; marilena.lasorda@policlinicogemelli.it 5 Plant Biotechnology, Université Libre de Bruxelles (ULB), CP300, Rue Prof. Jeener & Brachet 12, 6041 Gosselies, Belgium 1 Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy silvia.rizzo@unicatt.it (S.R.); mattia.dimercurio@unicatt.it (M.D.M.); melinda.mariotti@unicatt.it (M.M.); maurizio.sanguinetti@unicatt.it (M.S.); francesca.bugli@unicatt.it (F.B.) 2 Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy; stefania.garzoli@uniroma1.it |
AuthorAffiliation_xml | – name: 1 Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy silvia.rizzo@unicatt.it (S.R.); mattia.dimercurio@unicatt.it (M.D.M.); melinda.mariotti@unicatt.it (M.M.); maurizio.sanguinetti@unicatt.it (M.S.); francesca.bugli@unicatt.it (F.B.) – name: 3 Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy; marilena.lasorda@policlinicogemelli.it – name: 4 R&D Department, Pranarom International, 37 Avenue des Artisans, 7822 Ghislenghien, Belgium; azhiri@pranarom.com – name: 2 Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy; stefania.garzoli@uniroma1.it – name: 5 Plant Biotechnology, Université Libre de Bruxelles (ULB), CP300, Rue Prof. Jeener & Brachet 12, 6041 Gosselies, Belgium |
Author_xml | – sequence: 1 givenname: Carolina surname: Mastrella fullname: Mastrella, Carolina – sequence: 2 givenname: Silvia orcidid: 0009-0000-6104-0282 surname: Rizzo fullname: Rizzo, Silvia – sequence: 3 givenname: Maura Di orcidid: 0000-0002-2991-0855 surname: Vito fullname: Vito, Maura Di – sequence: 4 givenname: Stefania orcidid: 0000-0001-8535-0533 surname: Garzoli fullname: Garzoli, Stefania – sequence: 5 givenname: Mattia Di surname: Mercurio fullname: Mercurio, Mattia Di – sequence: 6 givenname: Melinda orcidid: 0000-0001-6901-0168 surname: Mariotti fullname: Mariotti, Melinda – sequence: 7 givenname: Marilena surname: La Sorda fullname: La Sorda, Marilena – sequence: 8 givenname: Abdesselam surname: Zhiri fullname: Zhiri, Abdesselam – sequence: 9 givenname: Maurizio orcidid: 0000-0002-9780-7059 surname: Sanguinetti fullname: Sanguinetti, Maurizio – sequence: 10 givenname: Francesca orcidid: 0000-0001-9038-3233 surname: Bugli fullname: Bugli, Francesca |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40143099$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl1r2zAUhs3oWD-2m_2AIdjNGKTTV2z5amQhXQOFjnXbrZBl2VGwpVSSA_mL-1U7Trq2GcMIW9Lj99U5es-zE-edybK3BF8yVuJPmxURmGFGyYvsjHDKJ4Ly4uTZ92l2HuMa42lBOHmVnXJMOMNleZb9Xjr0y6bg0V0a6h1KHi22qhtUMiitDPpiYkJz72qbrHcRXdt21cFI1rV7YOaS7a0OvrKqQzOd7NamHfINmqsw9EirsLVoEaMBEIhb2yHv0PXQK4e-qbTyrXFoGX0HlhFZh6586AeY7f1mrbIOjjBa3W2CUfUoPZpW1ier0XcTbUzKafM6e9moLpo3D--L7OfV4sf8enJz-3U5n91M9BSTNNFC16xUpmBFXVBSNrpSylChKi4Kjivd5EXO8nGTs7zKmRF13lDSNJRqUSp2kS0PurVXa7kJtldhJ72ycr_gQytVgKN1RjJTYTFtcsFFxVldg8kU2k5rVQq4OQxanw9am6HqTa2hSUF1R6LHO86uZOu3kpCST8tpAQofHhSCvx_gtmRvozZdp5zxQ5SMCCIoWFFA3_-Drv0QHPRqT-UEE5w_Ua2CCqxrPBjrUVTOBBOMEEwFUJf_oeCpDaQB8tlYWD_64d3zSh9L_BtFAD4eAMhSjME0jwjBcsy5fMo5-wPGhPDX |
Cites_doi | 10.3390/antibiotics9060346 10.3390/antibiotics11091215 10.1016/j.micpath.2019.103580 10.2174/0929867033457719 10.1080/09553002.2022.2078004 10.3390/jof3040057 10.3390/antibiotics12030591 10.1080/10408398.2017.1371112 10.3390/molecules26123625 10.1080/14786419.2021.1994566 10.1055/s-2006-962755 10.3390/antiox10020330 10.1021/jf0487351 10.1016/j.ijmm.2020.151435 10.1016/S0140-6736(21)02724-0 10.1080/87559129.2024.2357612 10.1038/s41579-022-00720-1 10.3390/foods12214017 10.4103/0973-7847.79101 10.1111/j.1469-0691.2011.03570.x 10.3390/antibiotics10040417 10.1093/infdis/jix131 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2025 MDPI AG 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2025 by the authors. 2025 |
Copyright_xml | – notice: COPYRIGHT 2025 MDPI AG – notice: 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2025 by the authors. 2025 |
DBID | AAYXX CITATION NPM 3V. 7XB 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO GNUQQ GUQSH M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.3390/ph18030321 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central ProQuest Central Student ProQuest Research Library ProQuest Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Open Access资源_DOAJ |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Basic ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1424-8247 |
ExternalDocumentID | oai_doaj_org_article_3eb085f6848b43dd8ab50992da983900 PMC11945957 A838311028 40143099 10_3390_ph18030321 |
Genre | Journal Article |
GeographicLocations | Italy Europe |
GeographicLocations_xml | – name: Italy – name: Europe |
GrantInformation_xml | – fundername: Ministero dell'università e della ricerca grantid: Project no. PE00000007, INF-ACT – fundername: Università Cattolica del Sacro Cuore grantid: Linea D1 – fundername: EU grantid: PE00000007 |
GroupedDBID | --- 2WC 53G 5VS 8G5 AADQD AAFWJ AAYXX ABDBF ABUWG ACGFO ACIHN ACUHS ADBBV AEAQA AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ CCPQU CITATION DIK DWQXO EBD ESX GNUQQ GROUPED_DOAJ GUQSH GX1 HH5 HYE IAO IHR ITC KQ8 M2O M48 MK0 MODMG M~E OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RPM TUS NPM PMFND 3V. 7XB 8FK MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c501t-c8cd39ae737d7219fcbaae28ab48740bcf676367d72436b63e8d6f21ff22c89a3 |
IEDL.DBID | M48 |
ISSN | 1424-8247 |
IngestDate | Wed Aug 27 01:30:33 EDT 2025 Thu Aug 21 18:39:53 EDT 2025 Wed Jul 02 05:14:49 EDT 2025 Mon Jun 30 12:02:18 EDT 2025 Tue Jun 17 21:55:15 EDT 2025 Tue Jun 10 03:43:15 EDT 2025 Sun Mar 30 01:28:21 EDT 2025 Tue Jul 01 05:21:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | DMSO antimicrobial resistance broth microdilution test Tween80 microatmosphere test disk diffusion test ethanol |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c501t-c8cd39ae737d7219fcbaae28ab48740bcf676367d72436b63e8d6f21ff22c89a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors also contributed equatlly to this work. These authors contributed equatlly to this work. |
ORCID | 0000-0001-8535-0533 0000-0002-2991-0855 0000-0001-9038-3233 0000-0001-6901-0168 0009-0000-6104-0282 0000-0002-9780-7059 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ph18030321 |
PMID | 40143099 |
PQID | 3181610106 |
PQPubID | 2032350 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3eb085f6848b43dd8ab50992da983900 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11945957 proquest_miscellaneous_3181820032 proquest_journals_3181610106 gale_infotracmisc_A838311028 gale_infotracacademiconefile_A838311028 pubmed_primary_40143099 crossref_primary_10_3390_ph18030321 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-02-25 |
PublicationDateYYYYMMDD | 2025-02-25 |
PublicationDate_xml | – month: 02 year: 2025 text: 2025-02-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Pharmaceuticals (Basel, Switzerland) |
PublicationTitleAlternate | Pharmaceuticals (Basel) |
PublicationYear | 2025 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Iacobellis (ref_17) 2005; 53 Tariq (ref_11) 2019; 134 ref_14 Murray (ref_3) 2022; 399 ref_13 ref_12 Ionescu (ref_19) 2011; 59 ref_10 Johri (ref_24) 2011; 5 ref_18 Maurya (ref_16) 2022; 36 Janssen (ref_26) 1987; 53 Aly (ref_15) 2023; 99 Magiorakos (ref_20) 2012; 18 ref_23 ref_22 Kalemba (ref_27) 2003; 10 ref_1 Arendrup (ref_21) 2017; 216 ref_2 ref_29 Chen (ref_25) 2024; 40 ref_9 ref_8 ref_4 Fisher (ref_5) 2022; 20 ref_7 ref_6 Sampers (ref_28) 2019; 59 |
References_xml | – ident: ref_7 doi: 10.3390/antibiotics9060346 – ident: ref_2 doi: 10.3390/antibiotics11091215 – volume: 134 start-page: 103580 year: 2019 ident: ref_11 article-title: A Comprehensive Review of the Antibacterial, Antifungal and Antiviral Potential of Essential Oils and Their Chemical Constituents Against Drug-Resistant Microbial Pathogens publication-title: Microb. Pathog. doi: 10.1016/j.micpath.2019.103580 – volume: 10 start-page: 813 year: 2003 ident: ref_27 article-title: Antibacterial and Antifungal Properties of Essential Oils publication-title: Curr. Med. Chem. doi: 10.2174/0929867033457719 – volume: 99 start-page: 318 year: 2023 ident: ref_15 article-title: Phytochemical Constitutes and Biological Activities of Essential Oil Extracted from Irradiated Caraway Seeds (Carum carvi L.) publication-title: Int. J. Radiat. Biol. doi: 10.1080/09553002.2022.2078004 – ident: ref_1 – ident: ref_6 doi: 10.3390/jof3040057 – ident: ref_18 doi: 10.3390/antibiotics12030591 – volume: 59 start-page: 357 year: 2019 ident: ref_28 article-title: A Review on Influencing Factors On the Minimum Inhibitory Concentration of Essential Oils publication-title: Crit. Rev. Food Sci. Nutr. doi: 10.1080/10408398.2017.1371112 – ident: ref_14 doi: 10.3390/molecules26123625 – ident: ref_23 – volume: 59 start-page: 440 year: 2011 ident: ref_19 article-title: Screening of the antibacterial and antifungal activity of eight volatile essential oils publication-title: Farm. J. – volume: 36 start-page: 4563 year: 2022 ident: ref_16 article-title: Mechanistic Investigations on Antifungal and Antiaflatoxigenic Activities of Chemically Characterised Carum carvi L. Essential Oil Against Fungal Infestation and Aflatoxin Contamination of Herbal Raw Materials publication-title: Nat. Prod. Res. doi: 10.1080/14786419.2021.1994566 – volume: 53 start-page: 395 year: 1987 ident: ref_26 article-title: Antimicrobial Activity of Essential Oils: A 1976–1986 Literature Review. Aspects of the Test Methods publication-title: Planta Med. doi: 10.1055/s-2006-962755 – ident: ref_8 – ident: ref_12 doi: 10.3390/antiox10020330 – volume: 53 start-page: 57 year: 2005 ident: ref_17 article-title: Antibacterial Activity of Cuminum cyminum L. and Carum carvi L. Essential Oils publication-title: J. Agric. Food Chem. doi: 10.1021/jf0487351 – ident: ref_4 – ident: ref_10 doi: 10.1016/j.ijmm.2020.151435 – ident: ref_29 – volume: 399 start-page: 629 year: 2022 ident: ref_3 article-title: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis publication-title: Lancet doi: 10.1016/S0140-6736(21)02724-0 – volume: 40 start-page: 3445 year: 2024 ident: ref_25 article-title: Minimum Inhibitory Concentration (MIC) of Essential Oils Against Microorganisms: Methods, Function, Accuracy Factors and Application publication-title: Food Rev. Int. doi: 10.1080/87559129.2024.2357612 – volume: 20 start-page: 557 year: 2022 ident: ref_5 article-title: Tackling the Emerging Threat of Antifungal Resistance to Human Health publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-022-00720-1 – ident: ref_13 doi: 10.3390/foods12214017 – volume: 5 start-page: 63 year: 2011 ident: ref_24 article-title: Cuminum cyminum and Carum carvi: An Update publication-title: Pharmacogn. Rev. doi: 10.4103/0973-7847.79101 – ident: ref_22 – volume: 18 start-page: 268 year: 2012 ident: ref_20 article-title: Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance publication-title: Clin. Microbiol. Infect. doi: 10.1111/j.1469-0691.2011.03570.x – ident: ref_9 doi: 10.3390/antibiotics10040417 – volume: 216 start-page: S445 year: 2017 ident: ref_21 article-title: Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment publication-title: J. Infect. Dis. doi: 10.1093/infdis/jix131 |
SSID | ssj0057141 |
Score | 2.3568833 |
Snippet | Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new... : In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is... Background/Objectives : In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new... Background/Objectives : In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 321 |
SubjectTerms | Antibiotics Antifungal agents Antimicrobial agents Bacteria broth microdilution test Caraway Chromatography disk diffusion test DMSO Dosage and administration Drug resistance Drug resistance in microorganisms E coli Essences and essential oils ethanol Fungal infections Health aspects Herbal medicine Mass spectrometry Metabolism microatmosphere test Microorganisms Oils & fats Pathogens Prevention Scientific imaging Staphylococcus infections Tween80 |
SummonAdditionalLinks | – databaseName: Open Access资源_DOAJ dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnrgg3gQWNAi0XDbaOM7DOXarVrtIQAW7aG-R7ThspN2katJD_yK_ipk4fUQcuHCtp40df5n5pvF8w9hHrjk9Qqkfp_TXTSyoWLlI_TRQIsxKDBKS6p2_fE0urqPPN_HNQasvOhPm5IHdjTsTViMrKBMZSR2JopBKY4zLwkJlGNuDPlvHmLdNppwPjlMecSdGKtDobHnLJaJZhHwUfnqV_r998UEwGh-UPIg888fs0UAZYeKm-oQ9sPVTdrJwmtObU7jal1C1p3ACi70a9eYZ-31Zw8-qWzVARwY30DUwcwrfFpD8wTlOBaYNvbkmBAId_LijjB1jWm8wqbvqvur1mmgWxrWbgKaEqVqt78Eo9DYwa6mKiSy-VXfQ1NC_HYAFEswGMQqXiHGitVDVMEeePHQNa2HyS1VIUftL_VgihS3op-miumpwSfDdtsRxEZzP2fV8djW98IcGDr6JA975RppCZMqmIi0w08xKo5WyIW5hRJ0AtSkTdG8JDUYi0YmwskjKkJdlGBqZKfGCHdVNbV8xCMrCmiTRaZyUEVIqFSiSspOB0RnmiIXHPmz3NV86nY4c8xva_Xy_-x47py3fWZC2dv8BIi4fEJf_C3Ee-0SAyckDICqMGgoZcKKkpZVPJGb9nIibx45HlvjkmvHwFnL54DnaHH0sknDK1D32fjdM36TTcLVt1s5G0qnC0GMvHUJ3S4pIsBGn6zE5wu5ozeORurrtdcU5z6I4i9PX_-MuvWEPQ2qVTNX_8TE76lZr-xb5W6ff9Y_qH9YJRfg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF5BeuGCeONS0CBQudSq7fVjfUJJlKpFokSlRb1Z-7BbS603xM4hf5FfxYztJLWQuGbX8Vr77ew3uzPfMPbZVz4tocSNEjq6iTglK5vETTzJg7TATUJQvvP38_j0Kvx2HV33B251H1a5sYmtoTZW0xn5MWIPyQl5MF8Xv12qGkW3q30JjcdsD02wECO2N5mdzy82tjhK_NDvREk5OvfHi1tfIKp54A-2oVat_1-b_GBTGgZMPtiBTp6xpz11hHE318_Zo7x6wQ7nnfb0-ggud6lU9REcwnynSr1-yf6cVfCrbJYWKHRwDY2FWaf0nQOSQJjgUGBq6QabkAgUAHJHnjvubW2HcdWU92Wr20Sj0F3ZCbAFTOVydQ9aotWBWU3ZTNTjR3kHtoL2lgDmSDQtYhXOEOtEb6Gs4AT5cl89rIbxjSyRqrav-rlAKmvor-mlqrT4SXCR18R1EaSv2NXJ7HJ66vaFHFwdeX7jaqENT2We8MSgx5kWWkmZB0KqkCoCKl3EaOZiagx5rGKeCxMXgV8UQaBFKvlrNqpslb9l4BUm13GskiguQqRW0pMkaSc8rVL0FY3DPm3mNVt0eh0Z-jk0-9lu9h02oSnf9iCN7fYHu7zJ-iWb8VwhHy1iEQoVcmNwuMiu0sDIFFml5znsCwEmI0uAqNCyT2jAgZKmVjYW6P37ROAcdjDoiStYD5s3kMt6C1JnO7w77OO2mZ6kqLgqt6uuj6DowsBhbzqEbj8pJOFGHK7DxAC7g28etlTlbasv7vtpGKVRsv__cb1jTwIqhkz5_dEBGzXLVf4eGVqjPvTL8C-6Dz9Q priority: 102 providerName: ProQuest |
Title | In Vitro Study to Evaluate the Best Conditions Highlighting the Antimicrobial Activity of Carum carvi Essential Oil on Human Pathogen Isolates in Formulations Against the Spread of Antibiotic Resistance |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40143099 https://www.proquest.com/docview/3181610106 https://www.proquest.com/docview/3181820032 https://pubmed.ncbi.nlm.nih.gov/PMC11945957 https://doaj.org/article/3eb085f6848b43dd8ab50992da983900 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELem7YUXxDcZozoEGi8rJHE-nAeE2qrVhrRRjRXtLbIdZ4vUJSVNJfov8ldxl6TtAjzxGl8SO77z_S72_Y6xd45yyITCvh_SrxufU7JyEvZDW3I3StFJCMp3Pr8ITmfel2v_eo9t6ne2H3D5z9CO6knNyvmHnz_Wn9HgP1HEiSH7x8WtI1BXOeWTH6BHCqmSwbm33U3wQ8dzGmrSP-Q7zqjm7P97Zb7nmrrHJu_5ockj9rAFkDBoZvwx2zP5E3Y8bRio1ydwtUuoWp7AMUx33NTrp-zXWQ7fs6osgA4QrqEqYNzwfRtAKAhD7AqMCtrHJn0EOgYyp_gdPVwtMMir7C6r2ZuoF7opPgFFCiNZru5AS1x7YLyknCaS-JrNocih3iuAKcLNAjUWzlDjCeRClsMEUXNbQ2wJgxuZIWCtX_VtgYA2oUfTS1VW4JDg0iwJ8aKqPmOzyfhqdNpvyzn0tW87VV8LnfBImpCHCcadUaqVlMYVUnlUF1DpNMDFLqBGjwcq4EYkQeo6aeq6WkSSP2f7eZGblwzsNDE6CFToB6mHAEvakojthK1VhBFjYrG3m3mNFw1rR4zRDs1-vJt9iw1pyrcSxLRdXyjKm7g13Jgbhag0DYQnlMeTBLuLGCtyExkhtrRti70nhYlJQ1ErtGzTGrCjxKwVDwQX3CEYZ7GjjiTase42b1Qu3phBjCsuQnKK2y32ZttMd9LZuNwUq0ZG0BlD12IvGg3dDskj-kbsrsVER3c7Y-625NltzTLuOJHnR354-P-3vmIPXCqXTAwA_hHbr8qVeY0YrlI9djAcX0wve_U_kF5trr8BXcdONg |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6V9AAXxBtDgUFAudSq7fVjfUAoCYkS2oaotFVvZr22W0utHRJHKH-KH8KvYsaPpBYSt16zG3uteX27O_MNY-_N0CQT8nTHo6Mbh1OxcuTpniG55ScYJATVOx9N3NGp_fXcOd9iv5taGEqrbHxi6aijXNEZ-T7qHoIT2sF8nv3UqWsU3a42LTQqtTiIV79wy7b4NP6C8v1gWcPBSX-k110FdOUYZqEroSLuy9jjXoTbHz9RoZSxJWRoU3u6UCUu2pxLgzZ3Q5fHInITy0wSy1LClxyfe4dt45hhddh2bzCZHje-3_FM26xIUDn3jf3ZpSnQirhltsJe2R3g3xhwIwi2EzRvRLzhA3a_hqrQrXTrIduKs0dsd1pxXa_24GRTurXYg12YbliwV4_Zn3EGZ2kxz4FSFVdQ5DComMVjQNAJPVwK9HO6MSfNB0o4uaKTAoyl5YRuVqTXackTRatQVZsLyBPoy_nyGpRELweDBVVP0Yxv6RXkGZS3EjBFYJujbcAYbYvgNKQZDBGf193KFtC9kClC4_JV32cInSN6NL00THP8JDiOF4St0SiesNNbEfFT1snyLH7OwEiiWLlu6DluYiOUk4YkCj1hqNDHvWmksXeNXINZxQ8S4L6KpB9spK-xHol8PYM4vcsf8vlFULuIgMch4t_EFbYIbR5FuFxEc74VSR9RrGFo7CMpTECeB7VCybqAAhdKHF5BV3DBTQKMGttpzUSPodrDjcoFtcdaBBv70tjb9TD9k7LwsjhfVnMEZTNaGntWaej6k2wiisTlaky0dLf1ze2RLL0s-cxN07cd3_Fe_H9db9jd0cnRYXA4nhy8ZPcsasRM3ALODusU82X8CtFhEb6uTRLYj9v2An8BC4980Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVEJcEG8MBQYB5VIrtteP9QGhJE3UUChRaVFvZr22W0utHWJHKH-Nn8CvYsaPpBYSt16zG3useX2zOw_G3pqhSSrk6Y5HRzcOp2LlyNM9Q3LLT9BJCKp3_nLkHpzan86csy32u62FobTK1iZWhjrKFZ2R91H2EJxQBNNPmrSI2f7k4_ynThOk6Ka1HadRi8hhvPqF4VvxYbqPvH5nWZPxyehAbyYM6MoxzFJXQkXcl7HHvQhDIT9RoZSxJWRo06i6UCUu6p9LizZ3Q5fHInITy0wSy1LClxyfe4ttexQV9dj2cHw0O279gOOZtlk3ROXcN_rzC1OgRnHL7LjAalLAv_7gmkPsJmte836Te-xuA1thUMvZfbYVZw_Y7qzue73ag5NNGVexB7sw23TEXj1kf6YZfE_LRQ6UtriCModx3WU8BgSgMERSYJTT7TlpAVDyySWdGqBfrTYMsjK9SqueUUSFqkdeQJ7ASC6WV6AkWjwYF1RJRTu-ppeQZ1DdUMAMQW6OegJT1DOC1pBmMEGs3kwuK2BwLlOEydWrvs0RRkf0aHppmOb4SXAcF4SzUUEesdMbYfFj1svyLH7KwEiiWLlu6DluYiOsk4akdnrCUKGPcWqksTctX4N53SskwBiLuB9suK-xIbF8vYP6e1c_5IvzoDEXAY9DxMKJK2wR2jyKkFxEdr4VSR8RrWFo7D0JTEBWCKVCyaaYAgmlfl7BQHDBTQKPGtvp7ETrobrLrcgFjfUqgo2uaez1epn-SRl5WZwv6z2CMhstjT2pJXT9STY1jURyNSY6stv55u5Kll5Uvc1N07cd3_Ge_Z-uV-w2an_weXp0-JzdsWgmM7UZcHZYr1ws4xcIFMvwZaORwH7ctBH4C42dgQY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vitro+Study+to+Evaluate+the+Best+Conditions+Highlighting+the+Antimicrobial+Activity+of+Carum+carvi+Essential+Oil+on+Human+Pathogen+Isolates+in+Formulations+Against+the+Spread+of+Antibiotic+Resistance&rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&rft.au=Mastrella%2C+Carolina&rft.au=Rizzo%2C+Silvia&rft.au=Vito%2C+Maura+Di&rft.au=Garzoli%2C+Stefania&rft.date=2025-02-25&rft.pub=MDPI&rft.eissn=1424-8247&rft.volume=18&rft.issue=3&rft_id=info:doi/10.3390%2Fph18030321&rft.externalDocID=PMC11945957 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon |